Skip to main content
PMC home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2009 May 8;24(1):88–93. doi: 10.1007/s12291-009-0015-0

Antidiabetic effect of Withania coagulans in experimental rats

Dolly Jaiswal 1, Prashant Kumar Rai 1, Geeta Watal 1,✉
PMCID: PMC3453475  PMID: 23105813

Abstract

The present study defines the systematic evaluation and the role of minerals in glycemic potential of aqueous extract of Withania coagulans fruits in order to develop an effective and safe alternative treatment for diabetes mellitus. Laser Induced Breakdown Spectroscopy was used for glycemic element detection. The study is based on the results of lowering in blood glucose levels of normal, sub, mild and severely diabetic rats assessed during fasting blood glucose, glucose tolerance test and post prandial glucose studies. The dose of 1000mg/ kg was identified as the most effective dose, which reduces the Fasting Blood Glucose level maximum by 33.2% at 4h in normal rats during fasting blood glucose studies. Glucose tolerance test studies of normal, sub and mild diabetic rats showed the maximum reduction of 15.7, 28.9 and 37.8% at 3h respectively. Long-term study in case of severely diabetic rats showed reduction of 52.9 and 54.1% in Fasting Blood Glucose and Post Prandial Glucose levels respectively after 30 days of treatment. The present study, besides confirming hypoglycemic and antidiabetic activities of aqueous extract of W. coagulans, helps in identifying the role of trace minerals like Mg & Ca responsible for antidiabetic potential of this potent indigenous shrub.

Key Words: Antidiabetic, Diabetes, Hypoglycemic, Indian Cheese maker, Withania coagulans

Full Text

The Full Text of this article is available as a PDF (273.4 KB).

References

  • 1.Singh SK, Rai PK, Jaiswal D, Watal G. Evidence based critical evaluation of glycemic potential of Cynodon dactylon. Evid Based Compliment Alternat Med (Available online from 17th May 2007) doi: 10.1093/ecam/nemo44. [DOI] [PMC free article] [PubMed]
  • 2.Chadha Y.R. The Wealth of India. New Delhi, India: Publication and Information Directorate CSIR; 1976. pp. 580–585. [Google Scholar]
  • 3.Kirtikar K.R., Basu B.D. Indian Medicinal Plants (CM Basu, Allahabad) 1933;2:1777–1781. [Google Scholar]
  • 4.Gaind K.N., Budhiraja R.D. Antibacterial and antihelmintic activity of Withania coagulans, Dunal. Ind J Pharmacol. 1967;29(6):185–186. [Google Scholar]
  • 5.Budhiraja R.D., Bala S., Craeg F.N., Arora B. Protective effect of 3-beta-hydroxy-2-3 dihydro withanolide-F against CCl4 induced hepatotoxicity. Planta Medica. 1986;1:28–29. doi: 10.1055/s-2007-969059. [DOI] [PubMed] [Google Scholar]
  • 6.Rajurkar SM, Thakre PN, Waddukar SG. Phytochemical and pharmacological screening of Withania coagulans berries as antiinflammatory. 53 IPC 2001, New Delhi, Dec., Sci. Abst CP38, 2001; p. 215.
  • 7.Hemalatha S., Sachdeva N., Wahi A.K., Singh P.N., Chansouria J.P.N. Effect of aqueous extract of fruits of Withania coagulans on glucose utilization by rat hemidiaphragm. Ind J Nat Prod. 2005;21(2):20–21. [Google Scholar]
  • 8.Brahm D., Trinder P. Estimation of glucose by glucose oxidase method. Analyst. 1972;97:142–145. doi: 10.1039/an9729700142. [DOI] [PubMed] [Google Scholar]
  • 9.Sabsabi M., Cielo P. Quantitative analysis of aluminum alloys by laser-induced breakdown spectroscopy and plasma characterization. Appl Spectrosc. 1995;49(4):499–507. doi: 10.1366/0003702953964408. [DOI] [Google Scholar]
  • 10.Kar A., Choudhary B.K. Important mineral content of a few ayurvedic herbs with a discussion on medicinal aspects. Indian Drugs. 1994;31(3):127–130. [Google Scholar]
  • 11.Kar A., Choudhary B.K., Bandyopadhyay N.G. Preliminary studies on the inorganic constituents of some indigenous hypoglycemic herbs on oral glucose tolerance test. J Ethnopharmacol. 1999;64(2):179–184. doi: 10.1016/S0378-8741(98)00118-4. [DOI] [PubMed] [Google Scholar]
  • 12.Gurson C.T., Saner G. Effect of chromium on glucose utilization in marasmic protein calorie mal nutrition. Am J Clin Nutr. 1971;24:1313–1319. doi: 10.1093/ajcn/24.11.1313. [DOI] [PubMed] [Google Scholar]
  • 13.Rai P.K., Rai N.K., Rai A.K., Watal G. Role of LIBS in elemental analysis of Psidium guajava responsible for glycemic potential. Instru Sci Techn. 2007;35(5):507–522. doi: 10.1080/10739140701540230. [DOI] [Google Scholar]
  • 14.Giugliano M., Bove M., Grattaro M. Insulin release at the molecular level: metabolic electro physiological modeling of pancreatic a-cells. IEEE Transactions on Biomedical Engineering. 2000;47:611–623. doi: 10.1109/10.841333. [DOI] [PubMed] [Google Scholar]
  • 15.Lopez-Ridaura R., Willett W.C., Rim E.B., Liu S., Stampfer M.J., Manson J.E., Hu F.B. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care. 2004;27(1):134–140. doi: 10.2337/diacare.27.1.134. [DOI] [PubMed] [Google Scholar]
  • 16.Fox C., Ramsoomair D., Carter C., Ny B. Magnesium: its proven and potential clinical significance. Southern Medical J. 2001;94(12):1195–1201. [PubMed] [Google Scholar]
  • 17.Veiga S., Leonelli E., Beelke M., Gareia-Segura V.M., Melcangi R.C. Neuroactive steroids prevent peripheral myelin alterations induced by diabetes. Neurosci Lett. 2006;02(1–2):150–153. doi: 10.1016/j.neulet.2006.03.058. [DOI] [PubMed] [Google Scholar]
  • 18.Pries E., Garrity L., Kays N., McDaniel P. 0023-Growth hormone treatment of a child with growth hormone deficiency, type I diabetes and chronic steroid use. J Pediatric Nursing. 2006;21:1–6. doi: 10.1016/j.pedn.2006.01.097. [DOI] [Google Scholar]
  • 19.Adebajo A.C., Ayoola O.F., Iwadewa E.O., Akindahunsi A.A., Omisore N.O.A., Adewunmi C.O., Adenowo T.K. Anti-trichomonal, biochemical and toxicological activities of methanolic extract and some carbajole alkaloids isolated from the leaves of Murraya koenigii growing in Nigeria. Phytomedicine. 2006;13(4):246–254. doi: 10.1016/j.phymed.2004.12.002. [DOI] [PubMed] [Google Scholar]
  • 20.Atta-ur-Rahman, Shabbir M., Yousaf M., Qureshi S., Dur-e-Shahwar N. A., Choudhary M.I. Three withanolids from Withania coagulans. Phytochemistry. 1999;52(7):1361–1364. doi: 10.1016/S0031-9422(99)00416-1. [DOI] [Google Scholar]
  • 21.Ramaiah P.A., Lavie D., Budhiraja R.D., Sudhir S., Garg K.N. Spectroscopic studies on a withanolide from Withania coagulans. Phytochemistry. 1984;23(1):143–149. doi: 10.1016/0031-9422(84)83095-2. [DOI] [Google Scholar]
  • 22.Sofowora A. Medicinal plants and traditional medicine in Africa. Bath, United Kingdom: John Willey and Sons; 1982. [Google Scholar]
  • 23.Lotlikar M.M., Rajarama R. Pharmacology of a hypoglycemic principle isolated from the fruits of Momordica charantia. Ind J Pharm. 1966;28:129–133. [Google Scholar]
  • 24.Hrinantenaina L., Tanaka M., Takaoka S., Oda M., Mogami O., Vchida M., Asakawa Y. Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chem Pharm Bull. 2006;54:1017–1021. doi: 10.1248/cpb.54.1017. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES